feed,title,long_url,short_url
Benzinga,"Protagonist Stock Moves Higher As Rusfertide Shows Durability Of Effect, Symptom Improvements In Blood Cancer Trial",https://benzinga.com/general/biotech/21/06/21530672/protagonist-stock-moves-higher-as-rusfertide-shows-durability-of-effect-symptom-improvements-in-b,https://j.mp/3iAGom8
